Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The role of molecular diagnosi...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
The role of molecular diagnosis and residual disease monitoring in APL: Results of the MRC ATRA trial.
Bibliographic Details
Main Authors:
Grimwade, D
,
Langabeer, S
,
Howe, K
,
Walker, H
,
Wheatley, K
,
Harrison, G
,
Goldstone, A
,
Burnett, A
,
Solomon, E
,
Parties, M
Format:
Journal article
Published:
1998
Holdings
Description
Similar Items
Staff View
Similar Items
Detection of minimal residual disease (MRD) in APL by "real-time" RT-PCR: Analysis of cases entered into the UK MRC ATRA trial.
by: Grimwade, D, et al.
Published: (1999)
The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
by: Grimwade, D, et al.
Published: (1999)
Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
by: Grimwade, D, et al.
Published: (1996)
Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial
by: Russell, N, et al.
Published: (2018)
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
by: Grimwade, D, et al.
Published: (1998)